$1.82 Billion is the total value of Endurant Capital Management LP's 56 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 88.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWN | New | ISHARES TRput | $1,554,935,000 | – | 108,600 | +100.0% | 85.25% | – |
| SPY | New | SPDR S&P 500 ETF TRput | $23,928,000 | – | 77,600 | +100.0% | 1.31% | – |
| OXFD | Sell | OXFORD IMMUNOTEC GLOBAL PLC | $18,158,000 | +15.6% | 1,396,795 | -17.6% | 1.00% | -86.0% |
| Buy | EVOLENT HEALTH INCnote 2.000%12/0 | $17,649,000 | +90.5% | 20,156,000 | +81.7% | 0.97% | -76.9% | |
| SIBN | Sell | SI BONE INC | $11,849,000 | -25.0% | 743,380 | -43.8% | 0.65% | -90.9% |
| JNJ | Buy | JOHNSON & JOHNSON | $11,796,000 | +85.5% | 83,879 | +73.0% | 0.65% | -77.6% |
| CNC | Buy | CENTENE CORP DEL | $10,807,000 | +376.3% | 170,057 | +345.2% | 0.59% | -42.4% |
| ZTS | Sell | ZOETIS INCcl a | $10,031,000 | +13.3% | 73,200 | -2.7% | 0.55% | -86.3% |
| ESPR | New | ESPERION THERAPEUTICS INC NE | $9,403,000 | – | 183,249 | +100.0% | 0.52% | – |
| EHC | Buy | ENCOMPASS HEALTH CORP | $8,744,000 | +145.5% | 141,195 | +153.9% | 0.48% | -70.3% |
| ANTM | Sell | ANTHEM INC | $7,897,000 | -19.8% | 30,028 | -30.7% | 0.43% | -90.3% |
| MDT | New | MEDTRONIC PLC | $6,953,000 | – | 75,828 | +100.0% | 0.38% | – |
| CI | Sell | CIGNA CORP NEW | $6,778,000 | -46.4% | 36,122 | -49.4% | 0.37% | -93.5% |
| ICUI | New | ICU MED INC | $6,553,000 | – | 35,556 | +100.0% | 0.36% | – |
| LH | Buy | LABORATORY CORP AMER HLDGS | $6,298,000 | +89.1% | 37,915 | +43.9% | 0.34% | -77.1% |
| OCUL | New | OCULAR THERAPEUTIX INC | $6,292,000 | – | 755,330 | +100.0% | 0.34% | – |
| ABBV | New | ABBVIE INC | $6,148,000 | – | 62,615 | +100.0% | 0.34% | – |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $5,495,000 | -42.2% | 46,038 | -51.1% | 0.30% | -93.0% |
| Buy | TRILLIUM THERAPEUTICS INC | $5,484,000 | +184.1% | 677,823 | +41.9% | 0.30% | -65.6% | |
| HMSY | New | HMS HLDGS CORP | $5,244,000 | – | 161,914 | +100.0% | 0.29% | – |
| SNY | Sell | SANOFIsponsored adr | $5,098,000 | -71.6% | 99,869 | -75.6% | 0.28% | -96.6% |
| SELB | Buy | SELECTA BIOSCIENCES INC | $5,053,000 | +721.6% | 1,779,328 | +596.9% | 0.28% | -0.7% |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $4,836,000 | +1011.7% | 483,103 | +202.3% | 0.26% | +34.5% |
| HOLX | Sell | HOLOGIC INC | $4,662,000 | -72.0% | 81,789 | -82.7% | 0.26% | -96.6% |
| PRTA | Buy | PROTHENA CORP PLC | $4,224,000 | +54.2% | 403,793 | +57.8% | 0.23% | -81.3% |
| HRC | Buy | HILL ROM HLDGS INC | $3,909,000 | +48.1% | 35,604 | +35.7% | 0.21% | -82.1% |
| INSM | Buy | INSMED INC | $3,861,000 | +223.9% | 140,184 | +88.5% | 0.21% | -60.7% |
| BSX | New | BOSTON SCIENTIFIC CORP | $3,734,000 | – | 106,338 | +100.0% | 0.20% | – |
| CALT | New | CALLIDITAS THERAPEUTICS ABsponsered ads | $3,717,000 | – | 160,218 | +100.0% | 0.20% | – |
| BAX | New | BAXTER INTL INC | $3,654,000 | – | 42,439 | +100.0% | 0.20% | – |
| SYNH | New | SYNEOS HEALTH INCcl a | $3,179,000 | – | 54,577 | +100.0% | 0.17% | – |
| MTEM | New | MOLECULAR TEMPLATES INC | $3,169,000 | – | 229,817 | +100.0% | 0.17% | – |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $2,801,000 | +2.8% | 1,728,787 | -34.0% | 0.15% | -87.5% |
| HAE | New | HAEMONETICS CORP | $2,592,000 | – | 28,937 | +100.0% | 0.14% | – |
| MCK | Sell | MCKESSON CORP | $2,446,000 | -50.3% | 15,942 | -56.2% | 0.13% | -94.0% |
| MBIO | New | MUSTANG BIO INC | $2,444,000 | – | 768,471 | +100.0% | 0.13% | – |
| UHS | New | UNIVERSAL HLTH SVCS INCcl b | $2,246,000 | – | 24,178 | +100.0% | 0.12% | – |
| IQV | Buy | IQVIA HLDGS INC | $2,238,000 | +148.9% | 15,773 | +89.3% | 0.12% | -69.8% |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $2,123,000 | -72.2% | 36,109 | -73.6% | 0.12% | -96.6% |
| FATE | Buy | FATE THERAPEUTICS INC | $2,089,000 | +130.8% | 60,892 | +49.5% | 0.12% | -72.0% |
| PRNB | Buy | PRINCIPIA BIOPHARMA INC | $1,817,000 | +242.8% | 30,395 | +240.5% | 0.10% | -58.3% |
| BIO | New | BIO RAD LABS INCcl a | $1,582,000 | – | 3,505 | +100.0% | 0.09% | – |
| XRAY | Sell | DENTSPLY SIRONA INC | $1,545,000 | -24.4% | 35,059 | -33.4% | 0.08% | -90.8% |
| BDX | Sell | BECTON DICKINSON & CO | $1,455,000 | -79.6% | 6,080 | -80.4% | 0.08% | -97.5% |
| FPRX | New | FIVE PRIME THERAPEUTICS INC | $1,447,000 | – | 237,174 | +100.0% | 0.08% | – |
| SENSEONICS HLDGS INCnote 5.250% 2/0 | $1,260,000 | -15.0% | 1,500,000 | 0.0% | 0.07% | -89.7% | ||
| STRO | New | SUTRO BIOPHARMA INC | $1,211,000 | – | 156,005 | +100.0% | 0.07% | – |
| AHCO | Sell | ADAPTHEALTH CORP | $1,143,000 | -67.7% | 71,000 | -67.9% | 0.06% | -96.1% |
| PTCT | New | PTC THERAPEUTICS INC | $998,000 | – | 19,677 | +100.0% | 0.06% | – |
| ZGNX | Sell | ZOGENIX INC | $799,000 | -45.0% | 29,575 | -49.7% | 0.04% | -93.3% |
| TCRR | New | TCR2 THERAPEUTICS INC | $591,000 | – | 38,494 | +100.0% | 0.03% | – |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $466,000 | – | 4,148 | +100.0% | 0.03% | – |
| PODD | New | INSULET CORP | $479,000 | – | 2,465 | +100.0% | 0.03% | – |
| GNCA | Sell | GENOCEA BIOSCIENCES INC | $276,000 | -39.3% | 119,979 | -54.6% | 0.02% | -92.7% |
| PCVX | New | VAXCYTE INC | $216,000 | – | 6,827 | +100.0% | 0.01% | – |
| ADCT | New | ADC THERAPEUTICS SA | $206,000 | – | 4,410 | +100.0% | 0.01% | – |
| KDMN | Exit | KADMON HLDGS INC | $0 | – | -61,188 | -100.0% | -0.12% | – |
| PETS | Exit | PETMED EXPRESS INC | $0 | – | -9,964 | -100.0% | -0.13% | – |
| OVID | Exit | OVID THERAPEUTICS INC | $0 | – | -116,297 | -100.0% | -0.16% | – |
| HCA | Exit | HCA HEALTHCARE INC | $0 | – | -5,666 | -100.0% | -0.23% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -87,703 | -100.0% | -0.23% | – |
| FLDM | Exit | FLUIDIGM CORP DEL | $0 | – | -232,291 | -100.0% | -0.27% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -20,207 | -100.0% | -0.27% | – |
| AVDL | Exit | AVADEL PHARMACEUTICALS PLCsponsored adr | $0 | – | -87,676 | -100.0% | -0.32% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -12,367 | -100.0% | -0.33% | – |
| ATRC | Exit | ATRICURE INC | $0 | – | -33,453 | -100.0% | -0.51% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -16,890 | -100.0% | -0.67% | – |
| CRL | Exit | CHARLES RIV LABS INTL INC | $0 | – | -13,147 | -100.0% | -0.75% | – |
| DVA | Exit | DAVITA INC | $0 | – | -27,164 | -100.0% | -0.94% | – |
| TAK | Exit | TAKEDA PHARMACEUTICAL CO LTDsponsored ads | $0 | – | -156,120 | -100.0% | -1.07% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -28,599 | -100.0% | -1.10% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -13,193 | -100.0% | -1.21% | – |
| AVTR | Exit | AVANTOR INC | $0 | – | -249,382 | -100.0% | -1.41% | – |
| PRAH | Exit | PRA HEALTH SCIENCES INC | $0 | – | -38,817 | -100.0% | -1.46% | – |
| RCM | Exit | R1 RCM INC | $0 | – | -484,801 | -100.0% | -2.00% | – |
| PFE | Exit | PFIZER INC | $0 | – | -510,150 | -100.0% | -7.55% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
| SC 13G/A | 2023-03-21 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.